AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, reported that the U.S. Food and Drug Administration (FDA) has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to Avance® Nerve Graft. AxoGen is a UF startup and graduate of UF Innovate | Sid Martin Biotech. The … Continue reading Axogen’s Avance Nerve Graft Receives Regenerative Medicine Advanced Therapy Designation (BioFlorida)